Cargando…
Presepsis biomarker: high-density lipoprotein
Autor principal: | Al-Zaidawi, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273924/ http://dx.doi.org/10.1186/cc14080 |
Ejemplares similares
-
Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
por: Su, J, et al.
Publicado: (2005) -
Could Decisions to Limit Treatment Contribute to Mortality Differences between Patients with Different Presepsis Trajectories?
por: Block, Brian L., et al.
Publicado: (2019) -
Prognostic Accuracy of Presepsis and Intrasepsis Characteristics for Prediction of Cardiovascular Events After a Sepsis Hospitalization
por: Walkey, Allan J., et al.
Publicado: (2022) -
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
por: Rodriguez, JM, et al.
Publicado: (2010) -
Inhibition of the lectin-like oxidized low-density lipoprotein receptor-1 improves intestinal microcirculation in experimental endotoxaemia
por: Lehmann, C, et al.
Publicado: (2009)